Seipin/BSCL2 has been identified as the pathogenic gene for Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) and induces the most severe form of lipodystrophy, characterized by an almost complete absence of adipose tissue and associated metabolic disorders. This evidence concerns the gene BSCL2 and metabolic disease.